CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹1,586 Cr | ₹1,213 Cr | ₹864 Cr | ₹689 Cr | ₹383 Cr |
What is the latest Capital Work in Progress ratio of CIPLA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹1,586 Cr |
| Mar2025 | ₹1,213 Cr |
| Mar2024 | ₹864 Cr |
| Mar2023 | ₹689 Cr |
| Mar2022 | ₹383 Cr |
How is Capital Work in Progress of CIPLA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,586 Cr | 30.80 | |
| Mar2025 | ₹1,213 Cr | 40.31 | |
| Mar2024 | ₹864 Cr | 25.41 | |
| Mar2023 | ₹689 Cr | 79.99 | |
| Mar2022 | ₹383 Cr | - | |
Compare Capital Work in Progress of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹118,078.6 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| MANKIND PHARMA | ₹100,137.0 Cr | -0.3% | -4.2% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.9% |
1.6% |
-2.5% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses